Testing FG001 in brain tumor patients before surgery
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a fluorescent dye called FG001 to see if it can help surgeons see brain tumors more clearly during surgery. It is for adults with a meningioma or a low-grade glioma who are scheduled to have their tumor removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain tumor seen on an MRI that looks like a meningioma or a low-grade glioma.
- You are scheduled for surgery to remove the tumor.
- You are 18 years old or older.
- You are able to understand and sign a consent form.
- If you could become pregnant, you agree to use birth control during the trial and for 30 days after.
- If you are male, you agree to use a condom during the trial and for 30 days after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
This study is testing whether a special dye called 5-ALA can help doctors see brain tumors more clearly during surgery. You may be able to join if you are scheduled for surgery to remove a suspected high-grade glioma.
This study tests a new dye called SBK2-ICG that helps surgeons see brain tumors more clearly during surgery. The dye is given before surgery and may help your doctor remove more of the tumor safely.
This trial tests a new kind of PET scan that uses a special tracer (Zr-89 crefmirlimab berdoxam) to help doctors see brain tumors more clearly before surgery. If you are scheduled to have your brain tumor removed, this scan may give your surgeon extra information to guide the operation.
This trial tests a special fluorescent dye (FG001) that helps surgeons see and remove high-grade brain tumors more completely during surgery. The dye is injected before surgery and glows under special light, potentially helping surgeons remove more tumor tissue safely.
This study tests whether using special fluorescent dye during brain tumor surgery, combined with chemotherapy and radiation, helps the body's immune system fight glioblastoma (an aggressive brain cancer). Researchers will track immune markers in your blood over time to understand how these treatments work together.
Hear when a new Low-grade Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.